News | May 10, 2023
Boehringer Ingelheim begins clinical development for fibrotic diseases
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Nous-209 has been developed using the Nouscom's viral vector platform
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
Subscribe To Our Newsletter & Stay Updated
